Richard Pitman

2.3k total citations
37 papers, 1.5k citations indexed

About

Richard Pitman is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Richard Pitman has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 11 papers in Infectious Diseases and 7 papers in Modeling and Simulation. Recurrent topics in Richard Pitman's work include Influenza Virus Research Studies (16 papers), Respiratory viral infections research (9 papers) and COVID-19 epidemiological studies (7 papers). Richard Pitman is often cited by papers focused on Influenza Virus Research Studies (16 papers), Respiratory viral infections research (9 papers) and COVID-19 epidemiological studies (7 papers). Richard Pitman collaborates with scholars based in United Kingdom, United States and Netherlands. Richard Pitman's co-authors include Nigel Gay, W. John Edmunds, Ben S. Cooper, Maarten J. Postma, Marc Brisson, David N. Fisman, Gregory S. Zaric, Mirjam Kretzschmar, John Edmunds and Ruby Siddiqui and has published in prestigious journals such as Journal of Bacteriology, PLoS Medicine and European Journal of Immunology.

In The Last Decade

Richard Pitman

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by Richard Pitman

Since Specialization

Citations

This map shows the geographic impact of Richard Pitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Pitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Pitman more than expected).

Fields of papers citing papers by Richard Pitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Pitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Pitman. The network helps show where Richard Pitman may publish in the future.

Co-authorship network of co-authors of Richard Pitman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Pitman. A scholar is included among the top collaborators of Richard Pitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Pitman. Richard Pitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The economic burden of varicella among children in France: a caregiver survey 2024 ·European Journal of Pediatrics ·(unknown), (unknown), (unknown), David R. Mink, Richard Pitman, Tanaz Petigara, Manjiri Pawaskar	1
2	EE106 Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model 2024 ·Value in Health ·(unknown), Lucie Kutikova, Richard Pitman, Kar Neng Lai, Hadi Beyhaghi, (unknown), (unknown), Catherine Cosgrove, Mark Sculpher, David Salisbury	0
3	Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands 2020 ·Value in Health ·Pieter T. de Boer, (unknown), F Christiaan K Dolk, Jan Wilschut, Richard Pitman, Maarten J. Postma	9
4	Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach 2020 ·Value in Health ·F Christiaan K Dolk, Pieter T. de Boer, (unknown), Gé Donker, Adam Meijer, Maarten J. Postma, Richard Pitman	9
5	Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report 2018 ·Value in Health ·Josephine Mauskopf, Baudouin Standaert, Mark P. Connolly, Anthony J. Culyer, Louis P. Garrison, Raymond Hutubessy, Mark Jit, Richard Pitman, Paul Revill, Johan L. Severens	89
6	Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States 2016 ·Value in Health ·Pieter T. de Boer, Pascal Crépey, Richard Pitman, (unknown), Ayman Chit, Maarten J. Postma	28
7	The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland 2016 ·PharmacoEconomics ·(unknown), Terho Heikkinen, (unknown), Richard Pitman	19
8	Retrospective public health impact of a quadrivalent influenza vaccine in the United States 2015 ·Influenza and Other Respiratory Viruses ·Pascal Crépey, Pieter T. de Boer, Maarten J. Postma, Richard Pitman	36
9	Cost-Effectiveness Comparison Of Quadrivalent Versus Trivalent Influenza Vaccines In The United States 2013 ·Value in Health ·Richard Pitman, (unknown), Evgeniya Antonova, David A. Scott	1
10	Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model 2012 ·Vaccine ·Richard Pitman, (unknown), Mark Sculpher	57
11	Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 2012 ·Value in Health ·Richard Pitman, David N. Fisman, Gregory S. Zaric, Maarten J. Postma, Mirjam Kretzschmar, John Edmunds, Marc Brisson	154
12	Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales 2011 ·Vaccine ·Richard Pitman, Lisa J. White, Mark Sculpher	46
13	Estimating the impact of childhood influenza vaccination programmes in England and Wales 2008 ·Vaccine ·Emilia Vynnycky, Richard Pitman, Ruby Siddiqui, Nigel Gay, W. John Edmunds	71
14	Assessing the burden of influenza and other respiratory infections in England and Wales 2006 ·Journal of Infection ·Richard Pitman, Alessia Melegaro, D. Gelb, Ruby Siddiqui, Nigel Gay, W. John Edmunds	130
15	Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation 2005 ·BMJ ·Richard Pitman, Ben S. Cooper, Caroline Trotter, Nigel Gay, W. John Edmunds	72
16	Human CD1d associates with prolyl-4-hydroxylase during its biosynthesis 2000 ·Molecular Immunology ·(unknown), Sean P. Colgan, Richard Pitman, Robert M. Hershberg, Richard S. Blumberg	8
17	Molecular Investigations Implicate Human Endogenous Retroviruses as Mediators of Anti-Retroviral Antibodies in Autoimmune Rheumatic Disease 1999 ·Immunological Investigations ·Paul N. Nelson, A. M. L. Lever, Robert J. Smith, Richard Pitman, Philip I. Murray, (unknown), O. M. R. Westwood, F C Hay, (unknown), James C. Booth	43
18	Dendritic cells from HIV-1-infected patients naturally express HIV-1 gp120 V3 loop-derived peptide ligands 1998 ·European Journal of Immunology ·(unknown), Richard Pitman, Catherine M. Hawrylowicz, A. D. M. Rees	1
19	CD4+ T-cell recognition of diverse clade B HIV-1 isolates 1997 ·AIDS ·(unknown), Sarah Fidler, Richard Pitman, Jonathan Weber, A. D. M. Rees	11
20	No Evidence of Antibody to Human Foamy Virus in Widespread Human Populations 1996 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Richard Pitman, David Parker, Axel Rethwilm, Rachanee Cheingsong‐Popov, Jonathan Weber, Paul D. Bieniasz, Janette E. Bradley, Myra O. McClure	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact